It was suggested that high expression levels of Beclin 1 and LC3B could inhibit the metastasis of CRC, Beclin 1 and LC3B hypo-expression might be employed to imply late development of CRC. This evidence concerns the gene MAP1LC3B and colorectal carcinoma.